ArticleApplied microbiology and biotechnology2026
Rapid and visual dual-color lateral flow immunoassay for african swine fever virus antibody detection.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African swine fever (ASF), an acute infectious disease with a high mortality rate, poses considerable challenges to the development of the global swine industry and socio-economic stability. At present, given the lack of commercial vaccines or effective therapeutic methods, the primary strategy for its management relies on rapid diagnosis and culling of infected animals. Thus, there is a pressing need to develop sensitive, simple, and rapid detection methods. In this study, a latex microsphere (LM)-based dual-color lateral flow immunoassay (LFIA) was designed for the detection of African swine fever virus (ASFV) antibody, which was detected within 15 min by the naked eye. Protein 72 (p72) was conjugated with red LM (RLM) and Chicken IgY (CIgY) with blue LM (BLM) to achieve dual-color detection. Moreover, no cross-reactivity was observed between the standard sera of ASFV and other common swine pathogens. The method exhibited a sensitivity of 1:1024, comparable with the commercial ELISA kit. Meanwhile, the evaluation of 159 clinical samples yielded a kappa value of 0.955. Regarding stability, the assay could be stored at 4℃, room temperature (18-25 ℃), and 37 ℃ for 16, 12, and 10 months, respectively. In addition, the intra- and inter-assay variability showed no significant difference, highlighting the excellent repeatability of the method. Overall, these results demonstrate that the dual-color LM-LFIA offers advantages such as low cost, high sensitivity, strong specificity, outstanding stability, and fast detection speed, making it particularly suitable for point-of-care testing (POCT) of ASF. KEY POINTS: • Visually intuitive: Within 15 min, a red C-line indicates a positive ASFV antibody. • Extremely high accuracy: Compared with commercial ASFV antibody ELISA kit, the Cohen's kappa value of this assay is 0.955. • Comparable sensitivity: The detection limit of this assay is 1:1024, matching the performance of a commercial ASFV ELISA kit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.